Antithrombotiques chez les patients atteints de COVID-19

CMAJ. 2022 Aug 8;194(30):E1074-E1075. doi: 10.1503/cmaj.220189-f.
[Article in French]
No abstract available

MeSH terms

  • Anticoagulants
  • COVID-19*
  • Fibrinolytic Agents*
  • Humans
  • Risk Factors

Substances

  • Anticoagulants
  • Fibrinolytic Agents